DE HB16 | 2023-2024 | 152nd General Assembly
Status
Spectrum: Moderate Partisan Bill (Democrat 18-3)
Status: Introduced on February 29 2024 - 25% progression
Action: 2024-05-22 - Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits
Text: Latest bill text (Draft #1) [HTML]
Status: Introduced on February 29 2024 - 25% progression
Action: 2024-05-22 - Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act requires that Medicaid and State employee health plans cover: (1) ovarian cancer monitoring tests for women treated for ovarian cancer; and (2) annual screening tests for women at risk for ovarian cancer.
Title
An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-22 | Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits | |
| 2024-05-21 | Amendment HA 1 to HB 16 - Introduced and Placed With Bill | |
| 2024-03-19 | Assigned to Appropriations Committee in House | |
| 2024-03-13 | Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits | |
| 2024-02-29 | Introduced and Assigned to Health & Human Development Committee in House |
